Brief: Glaukos Announces FDA Acceptance Of NDA Submission For Epioxa™
24/02/2025 13:24
Feb 24 (Reuters) - Glaukos Corp GKOS.N :
* GLAUKOS ANNOUNCES FDA ACCEPTANCE OF NDA SUBMISSION FOR
EPIOXA™
* GLAUKOS CORP - PDUFA DATE FOR EPIOXA NDA SET FOR OCTOBER
20,
2025
Source text: ID:nBw7SQ0rLa
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary